Picture of Biofarm SA logo

BIO Biofarm SA Share Price

0.000.00%
ro flag iconLast trade - 00:00
HealthcareBalancedSmall CapNeutral

Momentum

Relative Strength (%)
1m-1.78%
3m+1.29%
6m-6.94%
1yr+2.58%
Volume Change (%)
10d/3m-57.29%
Price vs... (%)
52w High-32.24%
50d MA-4.01%
200d MA-14.43%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital22.68%
Return on Equity20.49%
Operating Margin31.68%

Financial Summary

Year End 31st DecUnit201720182019202020212022E2023ECAGR / Avg
Total RevenueRONm170.23184.24202.76216.42239.04n/an/a9.46%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%+22.06+6.59+41.25+6.64+11.53n/an/an/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202231st Dec 2023
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2022 / 2023

Blurred out image of Biofarm SA EPS forecast chart

Profile Summary

Biofarm SA is a Romania-based company engaged in the pharmaceutical sector. The Company focuses on the production and marketing of pharmaceutical preparations. The Company is active in the manufacture and wholesale of over the counter drugs, prescription medications and dietary supplements. The Company’s product portfolio includes pharmaceutical preparations for digestive system, musculoskeletal system, immune stimulation, respiratory system, cold and flu symptoms and venous circulation improvement, as well as multivitamins, antioxidants, antiseptics, disinfectants and cosmetics, among others. Additionally, the Company offers services, such as consultancy on Romanian pharmaceutical market, manufacturing of non-sterile products, the investment in research, promotion and packaging. The main shareholder of the Company is Societatea de Investitii Financiare Muntenia SA.

Directors

Last Annual
December 31st, 2021
Last Interim
March 31st, 2022
Incorporated
February 5th, 1991
Public Since
November 19th, 1996
No. of Employees
376
Sector
Pharmaceuticals
Industry
Healthcare
Exchange
ro flag iconBucharest Stock Exchange
Shares in Issue
985,367,224

BIO Share Price Performance

Upcoming Events for BIO

Similar to BIO

Picture of Antibiotice SA logo

Antibiotice SA

ro flag iconBucharest Stock Exchange

Picture of Zentiva SA logo

Zentiva SA

ro flag iconBucharest Stock Exchange

FAQ

Or unlock with your email

Or unlock with your email